ACON
Aclarion IncKey Statistics
About Aclarion Inc
Aclarion Inc (ACON) is a leading healthcare technology company dedicated to enhancing patient care through non-invasive diagnostic solutions leveraging advanced data analytics and machine learning. The firm specializes in innovative imaging techniques that streamline treatment pathways for musculoskeletal conditions, equipping healthcare professionals with actionable insights to improve clinical outcomes while reducing costs. Positioned at the forefront of the digital health revolution, Aclarion is well-equipped to address the rising demand for effective diagnostic tools, significantly contributing to the evolution of healthcare delivery in a dynamic environment. With a strong focus on advancing patient management, Aclarion is set to redefine standards in the healthcare sector.
Fundamentals
| Revenue (TTM) | 75,730 |
| Gross Profit (TTM) | 6,830 |
| EBITDA | $-6.82M |
| Operating Margin | -10785.00% |
| Return on Equity | -104.80% |
| Return on Assets | -55.80% |
| Revenue/Share (TTM) | $0.14 |
| Book Value | $15.02 |
| Price-to-Book | 0.66 |
| Price-to-Sales (TTM) | 107.62 |
| EV/Revenue | 105.97 |
| EV/EBITDA | -0.56 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 80.60% |
| Shares Outstanding | $2.46M |
| Float | $2.04M |
| % Insiders | 9.91% |
| % Institutions | 1.22% |
Historical Volatility
Volatility is currently expanding